Vidakang is a bio-health product R&D and manufacturing company focused on natural-product biomanufacturing. Its core technology uses synthetic biology and microbial cell factories to produce valuable natural-product functional substances. This approach addresses limited plant sources, quality-control difficulties in cultivation, complex extraction and purification, and environmental pollution associated with traditional plant extraction. Vidakang recently completed a nearly ¥100 million Series A financing led by Yida Capital with Huachuang Yida participating. The funds will be used to continue innovation of its natural-product biomanufacturing technology platform, advance pipeline R&D, and expand global commercial operations.

Total raised

$14M

Funding rounds

1

Latest round

Series A

Latest activity

Jan 2024